SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Nektar Therapeutics
(NASDAQ : NKTR)

( )
NKTR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading NKTR News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
2.31%88.551.6%$823.72m
BIIBBiogen Inc.
-0.15%287.351.2%$582.20m
CELGCelgene Corporation
0.38%107.931.1%$475.08m
AMGNAmgen Inc.
0.54%166.561.2%$473.09m
REGNRegeneron Pharmaceuticals, Inc.
0.91%394.903.1%$311.76m
ALXNAlexion Pharmaceuticals, Inc.
1.32%127.462.6%$257.08m
TSROTESARO, Inc.
-1.05%91.0218.0%$220.16m
BMRNBioMarin Pharmaceutical Inc.
-0.84%92.793.9%$192.43m
ILMNIllumina, Inc.
-0.08%150.645.1%$157.78m
MDVNMedivation, Inc.
0.77%63.112.6%$134.52m
VRTXVertex Pharmaceuticals Incorporated
2.00%95.771.7%$133.83m
JUNOJuno Therapeutics, Inc.
0.65%29.327.9%$104.16m
AAgilent Technologies, Inc.
-0.92%46.151.9%$93.70m
INCYIncyte Corporation
0.02%86.432.2%$80.10m
ALNYAlnylam Pharmaceuticals, Inc
1.08%66.205.2%$63.94m

Company Profile

Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its products includes of drug candidates of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. The company provides small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. The company was founded in 1990 and is headquartered in San Francisco, CA.